Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)

ClinicalTrials.gov ID: NCT05634746

Public ClinicalTrials.gov record NCT05634746. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 9:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Fluticasone Propionate Oral Disintegrating Tablet Formulation in Eosinophilic Esophagitis: A Randomized, Double-blind, Placebo-Controlled 24-Week Induction Study of APT-1011, Followed by a Single-arm Open-label Extension, in Adult Subjects With Eosinophilic Esophagitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a 24-week randomized, double-blind, placebo-controlled induction study of APT-1011 in adults (≥18 years old) with eosinophilic esophagitis (EoE) followed by a single-arm, open-label extension. This study will evaluate the efficacy and safety of APT-1011 3 mg administered HS (hora somni, at bedtime) for the induction of response to treatment (symptomatic and histologic) over 24 weeks. The open-label extension will continue to evaluate long-term safety in subjects who consent to continue on open-label treatment with APT-1011.

Study identification

NCT ID
NCT05634746
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ellodi Pharmaceuticals, LP
Industry
Enrollment
218 participants

Conditions and interventions

Interventions

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 29, 2022 (Actual)
Primary completion
Aug 12, 2024 (Actual)
Completion
Aug 12, 2024 (Actual)
Last update posted
Aug 13, 2025

2022 – 2024

United States locations

U.S. sites
59
U.S. states
29
U.S. cities
57
Facility City State ZIP Site status
Digestive Health Specialists Dothan Alabama 36301 —
East View Medical Research LLC Mobile Alabama 36606 —
Premier Allergy Asthma and Immunology Scottsdale Arizona 85255 —
Del Sol Research Management, LLC. Tucson Arizona 85715 —
Preferred Research Partners, Inc. Little Rock Arkansas 72211 —
Arkansas Gastroenterology North Little Rock Arkansas 72117 —
Om Research LLC Camarillo California 93012 —
Providence Facey Medical Foundation Mission Hills California 91345 —
United Medical Doctors Murrieta California 92563 —
TriWest Research Associates, LLC San Diego California 92108 —
Precision Research Institute, LLC San Diego California 92114 —
Peak Gastroenterology Associates Colorado Springs Colorado 80907 —
Western States Clinical Research, Inc. Wheat Ridge Colorado 80033 —
Medical Research Center of Connecticut, LLC Hamden Connecticut 06518 —
Nature Coast Clinical Research Inverness Florida 34452 —
I.H.S Health, LLC Kissimmee Florida 34741 —
Endoscopic Research Inc Orlando Florida 32803 —
Revival Clinical Research Orlando Florida 32807 —
Gastroenterology Associates of Central Georgia, LLC Macon Georgia 31201 —
GI Alliance - Glenview Glenview Illinois 60026 —
GI Alliance - Gurnee Gurnee Illinois 60031 —
Deaconess Clinic Allergy Evansville Indiana 47715 —
Gastroenterology Health Partners, PLLC New Albany Indiana 47150 —
Velocity Clinical Research, Inc. Overland Park Kansas 66210 —
MGG Group Co., Inc., Chevy Chase Clinical Research Chevy Chase Maryland 20815 —
Gastro Center of Maryland, LLC Columbia Maryland 21045 —
Velocity Clinical Research, Inc. Rockville Maryland 20854 —
Boston Specialists Boston Massachusetts 02111 —
Clinical Research Institute of Michigan, LLC Chesterfield Michigan 48047 —
Henry Ford Health System Novi Michigan 48377 —
Clinical Research Institute of Michigan, LLC Troy Michigan 48098 —
Gastroenterology Associates of Western Michigan Wyoming Michigan 49519 —
MNGI Digestive Health, P.A. Plymouth Minnesota 55446 —
Clinical Research Professionals Chesterfield Missouri 63005 —
Bozeman Health Bozeman Montana 59715 —
Advanced Research Institute Reno Nevada 89511 —
New Mexico Clinical Research & Osteoporosis Center, Inc. Albuquerque New Mexico 87106 —
New York Gastroenterology Associates New York New York 10075 —
UNC Clinical and Translational Research Center (CTRC) Chapel Hill North Carolina 27599-7064 —
Charlotte Gastroenterology & Hepatology, PLLC Charlotte North Carolina 28207 —
Carolina Research Greenville North Carolina 27834 —
Bernstein Clinical Research Cincinnati Ohio 45236 —
Centricity Research Columbus Columbus Ohio 43213 —
Northshore Gastroenterology Research, LLC Westlake Ohio 44145 —
Vital Prospects Clinical Research Institute., PC Tulsa Oklahoma 74136 —
Perelman Center for Advanced Medicine Philadelphia Pennsylvania 19104 —
Frontier Clinical Research, LLC Uniontown Pennsylvania 15401 —
Rapid City Medical Center, LLP Rapid City South Dakota 57701 —
Texas Digestive Specialists Harlingen Texas 78550 —
GI Alliance Lubbock Texas 79410 —
GI Alliance Mansfield Texas 76063 —
Southern Star Research Institute, LLC. San Antonio Texas 78229 —
GI Alliance Webster Texas 77598 —
Advanced Research Institute Ogden Utah 84405 —
University of Utah Hospital Salt Lake City Utah 84132 —
Advanced Research Institute Sandy City Utah 84092 —
Blue Ridge Medical Research Lynchburg Virginia 24502 —
Washington Gastroenterology, PLLC dba GI Alliance Bellevue Washington 98004 —
GI Alliance Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05634746, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 13, 2025 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05634746 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →